Mitomycin-C® is an anticancer antibiotic produced by Streptomyces caespitosus first discovered by Hata et al. at the Kitasato Institute in 1955, and isolated by Wakaki et al. at Kyowa Hakko Kogyo (now Kyowa Hakko Kirin ) in the form of purple crystals.
Mitomycin-C® is used in the treatment of non-muscle-invasive bladder cancer, and some solid tumours and hematologic malignancies.
REPORTING OF SIDE EFFECTS
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects
not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at
By reporting side effects you can help provide more information on the safety of these medicines.